相关实验视频

Updated: Jan 8, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

膀癌的分子机制和转化进展:从驱动基因到精密疗法

Jinjie Xiang¹, Yuhui Luo¹, Baiyu Zhang¹

¹Department of Urology, First Affiliated Hospital of Kunming Medical University, Kunming, China.

Frontiers in oncology

|December 24, 2025

概括

精准医学通过准分子机制,推进了膀癌治疗. 研究突出了FGFR抑制剂,免疫疗法和基因疗法,未来重点是液体活检和人工智能以提供个性化护理.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

膀癌是一种复杂的泌尿系统恶性瘤,复发率高.
分子机制包括基因突变 (FGFR3,TP53/RB1),信号通路失调 (PI3K/AKT/mTOR,RAS-MAPK) 和表观遗传变化.
了解这些机制对于开发有效的诊断和治疗策略至关重要.

研究的目的:

系统地审查膀癌的翻译研究,将分子机制与精确疗法的突破联系起来.
总结针对性治疗的临床应用和挑战,如FGFR抑制剂和免疫疗法.
确定膀癌精准医学的研究缺口和未来方向.

主要方法:

关于膀癌的多学科研究和翻译研究的综合文献综述.
对当前精密疗法的临床应用和挑战进行分析.
识别新兴趋势和未来的研究途径.

主要成果:

多omics研究已经阐明了膀癌发病过程中的关键分子驱动因素和途径.
在精密疗法方面取得了重大进展,包括FGFR抑制剂,免疫检查点抑制剂,抗体药物合物和基因疗法.
分子亚型越来越多地用于开发特定亚型的治疗策略.

结论:

精密疗法在膀癌治疗方面取得了显著的进展,这是由分子洞察力驱动的.
剩余的挑战包括瘤异质性,治疗耐药性和生物标志物验证.
未来的方向包括液体活检,组合疗法,多omics数据集成和人工智能,用于个性化膀癌治疗.

关键词:

膀癌:膀癌是一种癌症.分子机制的分子机制.精密疗法是指精确的治疗方法.有针对性的治疗.翻译医学是一种翻译医学.

更多相关视频

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...